Harvard Bioscience Inc HBIO

$7.48 -0.93% at last close

Analyst Consensus

Consensus Rating
Hold (0 Buy · 1 Hold · 0 Sell)
Average Price Target
$7.50
Implied Upside
+0.3%
Price Target Range
$7.50 – $7.50
Analysts (12 mo)
1

Recent Analyst Actions

DateFirmActionRatingPrice Target
2026-08-12
BenchmarkBruce D. Jackson
 Maintains Speculative buy $6 → $8
2026-03-16
BenchmarkBruce D. Jackson
 Maintains Speculative buy $1 → $6
2026-03-13
BenchmarkBruce D. Jackson
 Maintains Speculative buy $2 → $1
2025-09-10
BenchmarkBruce D. Jackson
 Maintains Speculative buy $3 → $2
2025-05-13
BenchmarkBruce Jackson
 Maintains Speculative buy $5 → $3
2025-04-09
KeybancPaul Knight
 Downgrades Overweight → Sector weight —
2025-03-24
BenchmarkBruce Jackson
 Maintains Speculative buy $6 → $5
2023-06-22
BenchmarkBruce Jackson
 Reiterates Speculative buy $7
2023-04-26
BenchmarkBruce Jackson
 Maintains Buy $4 → $7
2023-04-26
KeybancPaul Knight
 Maintains Overweight $5 → $7
2023-03-10
BenchmarkKenneth Bruce
 Reiterates Buy $4
2022-11-09
KeybancPaul Knight
 Maintains Overweight $7 → $5
2022-08-05
KeybancPaul Knight
 Maintains Overweight $10 → $7
2020-11-10
KeybancPaul Knight
 Initiates coverage on Overweight $6
2020-02-27
BenchmarkBruce Jackson
 Maintains Speculative buy $4 → $4
2016-11-17
Singular Research
 Initiates coverage on Buy $6
2015-07-28
BenchmarkBruce Jackson
 Initiates coverage on Buy $8
2013-11-26
Sidoti & Co.
 Upgrades Neutral → Buy —

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$7.48
Market Cap
$34.05 million
52-Week Range
$3.75 – $9.40
Average Volume
18K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.